Quarterly report pursuant to Section 13 or 15(d)

Supplemental Cash Flow Information

v3.3.0.814
Supplemental Cash Flow Information
 9 Months Ended
Sep. 30, 2015
Notes  
Supplemental Cash Flow Information

12.  SUPPLEMENTAL CASH FLOW INFORMATION:

 

 

Nine months ended

September 30,

 

2015

 

2014

Cash paid for interest

$

25,356

 

$

229,571

Series C Dividend payable in accrued expenses

$

--

 

$

--

Series D Dividend payable in accrued expenses

$

40,084

 

$

53,054

 

 

 

 

 

 

Non-Cash investing and financing transactions

 

 

 

 

 

Shares issued for consulting services

$

25,500

 

$

--

Conversion of unsecured debt to secured note payable

$

20,000

 

$

--

Financing the purchase of equipment under a

4 year loan agreement

$

--

 

$

49,204

Beneficial conversion feature on warrants issued

in conjunction with Series D preferred shares

$

--

 

$

24,279

Shares issued in acquisition of Dr. Pave

$

--

 

$

175,000

Deemed dividend related to warrant extension

$

--

 

$

26,832